Search research articles
Contact Us
Filters
Showing results (161-170 of 231) with videos related to
Page
of 24
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Chemotherapy for bone marrow relapse of childhood acute lymphoblastic leukemia
G Henze, R Fengler, R Hartmann, et al.
Leukemia & Lymphoma
|
June 28, 2001
Absence of mutations in the CDKN2 binding site of CDK4 in childhood acute lymphoblastic leukemia
H G Einsiedel, T Taube, B Beyermann, et al.
Lancet (London, England)
|
September 30, 1995
Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. The Berlin-Frankfurt-Münster Study Group
A Borgmann, H Schmid, R Hartmann, et al.
Haematology and Blood Transfusion
|
January 1, 1990
Allogeneic bone marrow transplantation in childhood leukemia: results and strategies in the Federal Republic of Germany
D Niethammer, T Klingebiel, R Dopfer, et al.
Klinische Padiatrie
|
July 1, 1992
[Effect of cranial irradiation on rate of recurrence in children with acute myeloid leukemia. Initial results of the AML-BFM-87 study. The AML-BFM Study Group]
U Creutzig, J Ritter, P Heyen, et al.
European Journal of Pediatrics
|
January 7, 1999
Recommendations on the use of colony-stimulating factors in children: conclusions of a European panel
G Schaison, O B Eden, G Henze, et al.
Klinische Padiatrie
|
May 1, 1986
[Malignant melanoma in the child--2 case reports]
R Fengler, K Pankrath, E Baumgarten, et al.
Blood
|
November 1, 1994
Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86
A Reiter, M Schrappe, W D Ludwig, et al.
Blood
|
November 15, 1991
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study
R Dopfer, G Henze, C Bender-Götze, et al.
Blood
|
November 9, 2000
Oral isobutyramide reduces transfusion requirements in some patients with homozygous beta-thalassemia
S Reich, C Bührer, G Henze, et al.
Page
of 24
Search research articles
Search
Showing results (161-170 of 231) with videos related to
Sort By:
Page
of 24
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Chemotherapy for bone marrow relapse of childhood acute lymphoblastic leukemia
G Henze, R Fengler, R Hartmann, et al.
Leukemia & Lymphoma
|
June 28, 2001
Absence of mutations in the CDKN2 binding site of CDK4 in childhood acute lymphoblastic leukemia
H G Einsiedel, T Taube, B Beyermann, et al.
Lancet (London, England)
|
September 30, 1995
Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. The Berlin-Frankfurt-Münster Study Group
A Borgmann, H Schmid, R Hartmann, et al.
Haematology and Blood Transfusion
|
January 1, 1990
Allogeneic bone marrow transplantation in childhood leukemia: results and strategies in the Federal Republic of Germany
D Niethammer, T Klingebiel, R Dopfer, et al.
Klinische Padiatrie
|
July 1, 1992
[Effect of cranial irradiation on rate of recurrence in children with acute myeloid leukemia. Initial results of the AML-BFM-87 study. The AML-BFM Study Group]
U Creutzig, J Ritter, P Heyen, et al.
European Journal of Pediatrics
|
January 7, 1999
Recommendations on the use of colony-stimulating factors in children: conclusions of a European panel
G Schaison, O B Eden, G Henze, et al.
Klinische Padiatrie
|
May 1, 1986
[Malignant melanoma in the child--2 case reports]
R Fengler, K Pankrath, E Baumgarten, et al.
Blood
|
November 1, 1994
Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86
A Reiter, M Schrappe, W D Ludwig, et al.
Blood
|
November 15, 1991
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study
R Dopfer, G Henze, C Bender-Götze, et al.
Blood
|
November 9, 2000
Oral isobutyramide reduces transfusion requirements in some patients with homozygous beta-thalassemia
S Reich, C Bührer, G Henze, et al.
Page
of 24